Abstract | INTRODUCTION: METHODS: We performed a single-center retrospective study in a surgical intensive care unit of a tertiary hospital. Fifty consecutive TBI patients with refractory ICH treated with continuous HSS infusion adapted to a target of natremia. In brief, a physician set a target of natremia adapted to the evolution of intracranial pressure (ICP). Flow of NaCl 20% was a priori calculated according to natriuresis, and the current and target natremia that were assessed every 4 hours. RESULTS: The HSS infusion was initiated for a duration of 7 (5 to 10) (8 ± 4) days. ICP decreased from 29 (26 to 34) (31 ± 9) mm Hg at H0 to 20 (15 to 26) (21 ± 8) mm Hg at H1 (P < 0.05). Cerebral perfusion pressure increased from 61 (50 to 70) (61 ± 13) mm Hg at H0 up to 67 (60 to 79) (69 ± 12) mm Hg at H1 (P < 0.05). No rebound of ICH was reported after stopping continuous HSS infusion. Natremia increased from 140 (138 to 143) (140 ± 4) at H0 up to 144 (141 to 148) (144 ± 4) mmol/L at H4 (P < 0.05). Plasma osmolarity increased from 275 (268 to 281) (279 ± 17) mmol/L at H0 up to 290 (284 to 307) (297 ± 17) mmol/L at H24 (P < 0.05). The main side effect observed was an increase in chloremia from 111 (107 to 119) (113 ± 8) mmol/L at H0 up to 121 (117 to 124) (121 ± 6) mmol/L at H24 (P < 0.05). Neither acute kidney injury nor pontine myelinolysis was recorded. CONCLUSIONS: Continuous HSS infusion adapted to close biologic monitoring enables long-lasting control of natremia in TBI patients along with a decreased ICP without any rebound on infusion discontinuation.
|
Authors | Antoine Roquilly, Pierre Joachim Mahe, Dominique Demeure Dit Latte, Olivier Loutrel, Philippe Champin, Christelle Di Falco, Athanase Courbe, Kevin Buffenoir, Olivier Hamel, Corinne Lejus, Véronique Sebille, Karim Asehnoune |
Journal | Critical care (London, England)
(Crit Care)
Vol. 15
Issue 5
Pg. R260
( 2011)
ISSN: 1466-609X [Electronic] England |
PMID | 22035596
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Saline Solution, Hypertonic
- Sodium
|
Topics |
- Adult
- Brain Injuries
(blood, physiopathology, therapy)
- Dose-Response Relationship, Drug
- Female
- Fluid Therapy
(methods)
- Humans
- Infusions, Intravenous
(methods)
- Intracranial Hypertension
(blood, complications)
- Male
- Middle Aged
- Retrospective Studies
- Saline Solution, Hypertonic
(administration & dosage)
- Sodium
(blood)
- Treatment Outcome
|